GlassScriptPhysician profile
Hussam Hamdalla
NPI 1871527804
$24,275.85
in general payments reported to CMS, 2019-2025
58 companies · $7,582 in 2025
The $7,582 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,657 · 2020: $473 · 2021: $493 · 2022: $1,100 · 2023: $3,721 · 2024: $7,250 · 2025: $7,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,049 · Consulting Fee: $5,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,950 · Travel and Lodging: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,048.76 |
| Consulting Fee | $5,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,950.00 |
| Travel and Lodging | $1,053.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $10,515.37 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $3,037.92 | 2021-2025 | Onyx Frontier, Symplicity G3, Everflex Protege Everflex |
| Terumo Medical Corporation | $1,602.14 | 2019-2024 | Glidesheath Slender, Angio-Seal, Glidewire |
| Novartis Pharmaceuticals Corporation | $974.10 | 2019-2025 | |
| Boston Scientific Corporation | $862.31 | 2019-2025 | Avvigo Guidance System, Eluvia, Bodyguardian |
| Endologix LLC | $756.80 | 2019-2024 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Pfizer INC. | $683.82 | 2019-2025 | |
| Abbott Laboratories | $652.88 | 2019-2025 | Cardiomems, Optis, Jeti Peripheral Catheter |
| Abiomed | $559.03 | 2024-2025 | Impella |
| Amgen INC. | $495.62 | 2019-2025 | Repatha, Repatha |
| Avinger INC. | $424.69 | 2019-2023 | Pantheris |
| Sanofi-Aventis U.S. LLC | $269.52 | 2019-2023 | |
| Novo Nordisk INC | $264.17 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic Vascular, INC. | $236.05 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $200.19 | 2019-2025 | Lifevest |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $195.16 | 2022-2024 | Farxiga, Wainua |
| Asahi Intecc USA, INC. | $193.39 | 2023 | Asahi Ptca Guide Wire |
| Stryker Corporation | $174.29 | 2025 | Artix Mt |
| Inari Medical, INC. | $166.37 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $150.61 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Livanova USA, INC. | $144.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $143.43 | 2019-2022 | |
| Penumbra, INC. | $141.63 | 2025 | Indigo System |
| Kestra Medical Technology Services, INC. | $112.54 | 2025 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $105.60 | 2019 | |
| Baxter Healthcare | $96.55 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $85.75 | 2020-2024 | (5091) Amb Mon & Diag Und |
| Regeneron Healthcare Solutions, INC. | $84.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $79.04 | 2019-2024 | Camzyos |
| Cook Medical LLC | $74.34 | 2021 | |
| Angiodynamics, INC. | $61.78 | 2022-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Portola Pharmaceuticals, LLC | $53.91 | 2019 | |
| Lundbeck LLC | $51.58 | 2019 | |
| Inspire Medical Systems, INC. | $50.93 | 2024-2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $47.95 | 2024-2025 | Onpattro |
| Amarin Pharma, INC. | $40.78 | 2019-2020 | |
| Atricure, INC. | $39.20 | 2023-2025 | Synergy Ablation System |
| Biotronik INC. | $38.17 | 2019 | |
| Chiesi USA, INC. | $37.27 | 2019 | |
| Merck Sharp & Dohme LLC | $33.83 | 2024-2025 | Verquvo |
| Teleflex LLC | $33.62 | 2025 | Turnpike |
| Scpharmaceuticals INC. | $26.47 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $25.61 | 2019 | |
| Impulse Dynamics (USA) INC. | $24.25 | 2024 | Optimizer |
| Bolton Medical INC | $23.64 | 2025 | Treo Abdominal Stent-Graft System |
| Organogenesis INC. | $23.53 | 2023 | Puraply |
| Actelion Pharmaceuticals US, INC. | $23.27 | 2021-2022 | |
| Acacia Pharma INC | $19.66 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.74 | 2022 | |
| Corcept Therapeutics | $18.28 | 2025 | Korlym |
| Corindus INC. | $18.25 | 2019 | |
| Cardiva Medical, INC. | $17.74 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Imperative Care, INC | $15.56 | 2023 | Symphony Catheter |
| Esperion Therapeutics, INC. | $15.51 | 2025 | Nexletol |
| Cardiovascular Systems INC. | $12.86 | 2019 | |
| Cvrx, INC. | $11.80 | 2023 | Barostim Neo System |
| Surmodics, INC. | $9.35 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hussam Hamdalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.